Aldeyra Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aldeyra Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Aldeyra Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 59.5M shares, a 0.61% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 59.5M +362K +0.61% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 59.4M +613K +1.04% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 59.4M +623K +1.06% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 59.2M +636K +1.09% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 59.2M +627K +1.07% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 58.8M +500K +0.86% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 58.8M +490K +0.84% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 58.6M +479K +0.82% Dec 31, 2022 10-K 2024-03-07
Q3 2022 58.6M +515K +0.89% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 58.3M +304K +0.52% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 58.3M +10.7M +22.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 58.1M +19.4M +50.2% Dec 31, 2021 10-K 2023-03-09
Q3 2021 58M +19.4M +50.3% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 58M +25M +75.8% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 47.7M +18.1M +61.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 38.7M +10M +34.9% Dec 31, 2020 10-K 2022-03-17
Q3 2020 38.6M +11.5M +42.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 33M +6.01M +22.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 29.5M +2.6M +9.65% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 28.7M +2.41M +9.19% Dec 31, 2019 10-K 2021-03-11
Q3 2019 27.2M +6.16M +29.4% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 27M +6.14M +29.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 26.9M +7.25M +36.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 26.2M +7.11M +37.1% Dec 31, 2018 10-K 2020-03-12
Q3 2018 21M +1.87M +9.79% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 20.8M +5.69M +37.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 19.7M +4.53M +30% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 19.1M +6.56M +52.2% Dec 31, 2017 10-K 2019-03-08
Q3 2017 19.1M +6.55M +52.1% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 15.2M +2.68M +21.5% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 15.1M +5.42M +55.8% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 12.6M +2.86M +29.5% Dec 31, 2016 10-K 2018-03-29
Q3 2016 12.6M +2.86M +29.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 12.5M +2.76M +28.4% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 9.71M +2.82M +41% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 9.71M +4.15M +74.5% Dec 31, 2015 10-K 2017-03-30
Q3 2015 9.71M +4.15M +74.5% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 9.71M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 6.89M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 5.57M +5.24M +1600% Dec 31, 2014 10-K 2016-03-30
Q3 2014 5.57M Sep 30, 2014 10-Q 2014-11-12
Q4 2013 327K Dec 31, 2013 10-Q 2014-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.